COMP <GO>
INSM vs VTRS // ENTERPRISE SCALE & MARKET CAP
Insmed Incorporated (NASDAQ) VS. Viatris Inc. (NASDAQ) • 15-METRIC TALLY: INSM 5
— VTRS 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: INSM
LAST: $109.31 (-2.90%) • MKT CAP: $24.70B
market-cap
$24.70B
LAST: $18.67 (-1.92%) • MKT CAP: $21.86B
market-cap
$21.86B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INSM VS. VTRS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INSM | VTRS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.70% | 35.20% | +44.50 | INSM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -8.10% | -26.90 | VTRS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.97% | 8.78% | -12.75 | VTRS | /fcf-yield <GO> |
| Operating Margin | -60.00% | -18.70% | -41.30 | VTRS | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -14.60% | -45.40 | VTRS | /net-margins <GO> |
| Revenue Growth (YoY) | 66.70% | -3.00% | +69.70 | INSM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.25 | 0.81 | +4.44 | INSM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | VTRS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.2 | 62.5 | -0.30 | VTRS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.03 | 1.15 | -0.12 | VTRS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 33.0x | -12.00 | INSM | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $24.70B | $21.86B | $2.83B | INSM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INSM REV | VTRS REV | INSM GROSS % | VTRS GROSS % | INSM FCF | VTRS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $606.4M | $14.25B | 79.7% | 35.2% | -$967.6M | $1.94B |
| FY 2024 | $363.7M | $14.69B | 76.4% | 38.3% | -$705.8M | $1.98B |
| FY 2023 | $305.2M | $15.39B | — | — | -$550.0M | $2.21B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INSM // BETA 1.03
VTRS // BETA 1.15